secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001193125-25-072397
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose receives Nasdaq delisting notice for equity non-compliance; shares to be delisted Apr 2
--------------------------------------------------------------------------------

- Nasdaq determined to delist Aptose effective April 2, 2025 for failure to meet minimum stockholder equity requirement under Rule 5550(b)(1).
- Company received the delisting notice on March 31, 2025; will review options including appeal.
- Aptose intends to continue executing business plan and seek listing on a U.S. national securities exchange.
- Common shares remain listed on the Toronto Stock Exchange (TSX) under symbol 'APS'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525072397/0001193125-25-072397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525072397/d945844d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-072397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer